The US Dept of Veterans Affairs conducted deep-dive study into effects of COVID-19 on Veterans
On May 28, 2020, the U.S. Dept. of Veterans Affairs (VA) began a national four-year study on the…
Biogen and MIT launched virtual learning lab for high school students historically underrepresented in science
On May 28, 2020, Biogen and the Lemelson-MIT Program (LMIT) at the Massachusetts Institute of Technology announced the…
Vaxxas announced that Merck exercised option to apply novel immune system activation platform for Vaccine candidate
On May 28, 2020, Vaxxas announced that Merck had exercised its option to utilize Vaxxasﾒ proprietary High Density…
FDA authorized Quest Diagnostics COVID-19 Nasal Specimen Self-Collection Kit for emergency use
On May 28, 2020, Quest Diagnostics announced it had received emergency use authorization (EUA) from the FDA for…
Roche initiated phase III clinical trial of Actemra/RoActemra plus remdesivir in hospitalised patients with severe COVID-19 pneumonia
On May 28, 2020, Roche announced it had initiated of a global phase III, randomised, double-blind, multicentre study…
Atossa Therapeutics announced second COVID-19 therapeutic development program, AT-301 nasal spray
On May 28, 2020, Atossa Therapeutics announced that it had begun the development of a second COVID-19 program…
NIH released strategic plan to accelerate nutrition research over next 10 years
On May 27, 2020, the NIH Nutrition Research Task Force (NRTF), armed with insights from the nutrition science…
Biotechnology | Diagnostics | Neurology | NIH
NIH study showed markers in blood can help identify risk for complications after Brain Injury
On May 27, 2020, the National Institutes of Health (NIH) announced it had found that molecules released into…
Gilead and Arcus Biosciences established 10-year partnership to co-develop and co-commercialize next-generation cancer immunotherapies
On May 27, 2020, Gilead Sciences and Arcus Biosciences announced that the companies had entered into a 10-year…
International gnomAD Consortium released first major studies of human genetic variation
On May 27, 2020, an analyses of the largest publicly available catalog of human genomic data revealed new…
Novavax expanded large-scale global manufacturing capacity
On May 27, 2020, Novavax announced the acquisition of Praha Vaccines, part of the Cyrus Poonawalla Group, in…
Heat Biologics announced collaboration with Waisman Biomanufacturing to manufacture COVID-19 vaccine
On May 27, 2020, Heat Biologics announced a collaboration with Waisman Biomanufacturing to establish a partnership for the…
Quest Diagnostics launched COVID-19 workforce testing services to help organizations in fostering safer workplaces
On May 27, 2020, Quest Diagnostics launched a new suite of Return to Work services built around large-scale…
Sanofi announced pricing of Regeneron stock offering
On May 26, 2020, Sanofi announced that it had agreed to sell 11.8 million shares of Regeneron common…
Women with Neandertal gene give birth to more children
On May 26, 2020, researchers at the Max Planck Institute for Evolutionary Anthropology in Germany and the Karolinska…
IAVI and Merck announced collaboration to develop vaccine against SARS-CoV-2
On May 26, 2020, Merck and and IAVI, a nonprofit scientific research organization dedicated to addressing urgent, unmet…
Study confirmed effective, less toxic alternative to standard treatment for adults with Burkitt lymphoma
On May 26, 2020, the NIH announced a new study that provides an alternative treatment regimen that is…
The FDA approved only drug in U.S. to treat severe malaria
On May 26, 2020, the FDA approved Amivas’ artesunate for injection to treat severe malaria in adult and…
Philips launched next generation wearable biosensor for early patient deterioration detection for COVID-19
On May 26, 2020, Royal Philips announced it had received 510(k) clearance from the FDA for its wearable…
GenScript announced CE-IVD for neutralizing antibody test kit of SARS-CoV-2 and COVID-19 diagnostics
On May 26, 2020, GenScript Biotech announced that it had obtained CE-IVD for its SARS-CoV-2 diagnostic products to…
Dementia gene raises risk of severe COVID-19
On May 26, 2020, researchers at the University of Exeter Medical School and the UConn School of Medicine…
Merck and Ridgeback Bio announced collaboration to advance development of novel antiviral candidate, EIDD-2801
On May 26, 2020, Merck and and and Ridgeback Biotherapeutics announced a collaboration agreement to develop EIDD-2801, an…
Innovation Pharma receives data from public health research institute showing brilacidin inhibits SARS-CoV-2 (COVID-19) in human cell line
On May 26, 2020, Innovation Pharma reported receiving data from a leading public health research institute showing Brilacidin…
Cerecor and Myriad Genetics announced levels of novel cytokine, LIGHT highly correlated with disease severity and mortality in COVID-19 ARDS biomarker study
On May 26, 2020, Cerecor and Myriad Genetics announced that levels of novel cytokine, LIGHT, were highly correlated…
Novavax initiated phase 1/2 clinical trial of COVID-19 vaccine
On May 26, 2020, Novavax announced enrollment of the first participants in a Phase 1/2 clinical trial of…
The FDA approved only drug in the U.S. to treat severe malaria
On May 26, 2020, the FDA provided approval to Amivas for its artesunate for injection to treat severe…
University of Nebraska Medical Center Landmark study showed no benefit of drug to slow growth of aneurysms
On May 26, 2020, University of Nebraska Medical Center (UNMC) researchers were part of a large national study…
Montefiore and Einstein tested new drug combination to conquer COVID-19
On May 26, 2020, Montefiore Health System and Albert Einstein College of Medicine began the next stage of…
Todos Medical announced cross-distribution agreement with L1 Systems for ventilators and COVID testing
On May 26, 2020, Todos Medical announced it had entered into a cross-distribution agreement with L1 Systems, a…
Meridian Bioscience suppied reagents for manufacturing of tens of millions of COVID-19 antibody tests per month
On May 26, 2020, Meridian Bioscience announced that its SARS-CoV-2 antigens and related reagents are part of assays…